Borosil Scientific: mixed financials for Q2 and H1 FY26

For Q2 FY26, Borosil Scientific reported standalone net sales of ₹99.5 Crs, a 13.8% increase year-on-year, with EBITDA at ₹14.6 Crs, down 4.1%. Consolidated net sales for the quarter reached ₹106.9 Crs, up 3.8% year-on-year, but consolidated EBITDA saw a significant decline of 41.5% to ₹10.2 Crs. The consolidated PAT for Q2 FY26 was ₹2.8 Crs, a 67.7% decrease from the previous year.

Half-year results (H1 FY26) show standalone net sales of ₹188.5 Crs, up 4.1%, and consolidated net sales of ₹202.9 Crs, a decrease of 2.3% year-on-year. Consolidated EBITDA for H1 FY26 was ₹18.0 Crs, down 38.8%, and the consolidated PAT was a negative ₹1.4 Crs, a 109.9% decrease. This decline was primarily attributed to one-time expenses related to discontinued operations at the Ambad manufacturing plant, including fixed asset discarding and a Voluntary Retirement Scheme (VRS) for eligible workers, which incurred an exceptional expense of ₹6.61 crores.

Despite short-term impacts, the company's Scientific Segment saw growth in Lab Consumables and Lab Equipments, with sales up 15.3% and 25.5% respectively in Q2 FY26. The Process System segment experienced a 53.4% decline in Q2 FY26 due to a lower opening order book and deferred customer orders. Pharma Packaging showed stable performance, while Domestic Glassware grew by 18.2% in Q2 FY26.